Enhancing Capital LLC Takes $476,000 Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

Enhancing Capital LLC acquired a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,434 shares of the company's stock, valued at approximately $476,000.

Several other institutional investors and hedge funds have also modified their holdings of MEDP. Pallas Capital Advisors LLC raised its position in Medpace by 179.7% in the fourth quarter. Pallas Capital Advisors LLC now owns 3,270 shares of the company's stock valued at $1,086,000 after purchasing an additional 2,101 shares during the last quarter. Barclays PLC raised its position in Medpace by 71.9% in the third quarter. Barclays PLC now owns 19,781 shares of the company's stock valued at $6,603,000 after purchasing an additional 8,275 shares during the last quarter. Sanctuary Advisors LLC raised its position in Medpace by 20.5% in the fourth quarter. Sanctuary Advisors LLC now owns 4,964 shares of the company's stock valued at $1,738,000 after purchasing an additional 844 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Medpace in the third quarter valued at about $3,098,000. Finally, Loomis Sayles & Co. L P raised its position in Medpace by 7.2% in the third quarter. Loomis Sayles & Co. L P now owns 205,798 shares of the company's stock valued at $68,696,000 after purchasing an additional 13,880 shares during the last quarter. 77.98% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird increased their target price on Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $381.44.

Remove Ads

Medpace Trading Up 1.4 %

NASDAQ MEDP traded up $4.60 during trading hours on Friday, hitting $324.23. 434,202 shares of the company's stock were exchanged, compared to its average volume of 289,354. The stock has a 50-day simple moving average of $337.72 and a 200 day simple moving average of $339.82. Medpace Holdings, Inc. has a 1-year low of $302.01 and a 1-year high of $459.77. The firm has a market cap of $9.88 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP - Get Free Report) last released its earnings results on Monday, February 10th. The company reported $3.67 EPS for the quarter, topping the consensus estimate of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. On average, sell-side analysts anticipate that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.